School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia.
Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Australia.
J Am Med Dir Assoc. 2019 Mar;20(3):362-372.e11. doi: 10.1016/j.jamda.2018.10.026. Epub 2018 Dec 21.
Deprescribing is effective in addressing concerns relating to polypharmacy in residents of nursing homes. However, the clinical outcomes of deprescribing interventions among residents in nursing homes are not well understood. We evaluated the impact of deprescribing interventions by health care professionals on clinical outcomes among the older residents in nursing homes.
Systematic review and meta-analysis of randomized controlled trials. CINAHL, International Pharmaceutical Abstracts, MEDLINE, EMBASE, and Cochrane Library were searched from inception until September 2017; manual searches of reference lists of systematic reviews identified in the electronic search; and online trial registries for unpublished, ongoing, or planned trials. (PROSPERO CRD42016050028).
Randomized controlled trials in a nursing home setting that included participants of at least 60 years of age.
Falls, all-cause mortality, hospitalization, and potentially inappropriate medication were assessed in the meta-analysis.
A total of 41 randomized clinical studies (18,408 residents) that examined deprescribing (defined as either medication discontinuation, substitution, or reduction) in nursing were identified. Deprescribing interventions significantly reduced the number of residents with potentially inappropriate medications by 59% (odds ratio [OR] 0.41, 95% confidence interval [CI] 0.19-0.89). In subgroup analysis, medication review-directed deprescribing interventions reduced all-cause mortality by 26% (OR 0.74, 95% CI 0.65-0.84), as well as the number of fallers by 24% (OR 0.76, 95% CI 0.62-0.93).
Compared to other deprescribing interventions, medication review-directed deprescribing had significant benefits on older residents in nursing homes. Further research is required to elicit other clinical benefits of medication review-directed deprescribing practice.
在养老院居民中,减少用药(Deprescribing)可有效解决多种药物治疗的相关问题。然而,减少用药干预对养老院居民临床结局的影响尚不清楚。我们评估了医疗保健专业人员实施的减少用药干预对养老院老年居民临床结局的影响。
对随机对照试验进行系统评价和荟萃分析。从建库起至 2017 年 9 月,我们检索了 CINAHL、国际药学文摘、MEDLINE、EMBASE 和 Cochrane Library;通过电子检索确定的系统评价参考文献列表的手工检索;以及未发表、正在进行或计划进行的试验的在线试验注册处。(PROSPERO CRD42016050028)。
在养老院环境中进行的随机对照试验,纳入了至少 60 岁的参与者。
荟萃分析评估了跌倒、全因死亡率、住院和潜在不适当药物的情况。
共确定了 41 项研究(18408 名居民),这些研究检验了减少用药(定义为药物停用、替代或减少)在养老院中的应用。减少用药干预显著减少了 59%的潜在不适当药物使用者(比值比[OR]0.41,95%置信区间[CI]0.19-0.89)。在亚组分析中,药物审查指导的减少用药干预使全因死亡率降低了 26%(OR 0.74,95% CI 0.65-0.84),跌倒人数减少了 24%(OR 0.76,95% CI 0.62-0.93)。
与其他减少用药干预相比,药物审查指导的减少用药对养老院老年居民具有显著益处。需要进一步研究以确定药物审查指导的减少用药实践的其他临床益处。